-
EP3003289
European procedure
Extract from the Register of European Patents
EP Citations: EP3003289
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2004096221
[XY] (MORPHOCHEM AG KOMB CHEMIE [DE], et al) [X] 2,4-13,15-29,32 * p. 21, l.26-28; p. 64, example 73 * [Y] 1-13,15-32; | Type: | Patent literature | Publication No.: | WO2005058888
[XY] (MORPHOCHEM AG [DE], et al) [X] 2,4-13,15-29,32 * example 7; p. 12, l. 32 * [Y] 1-13,15-32; | Type: | Patent literature | Publication No.: | WO2009136379
[XY] (ACTELION PHARMACEUTICALS LTD [CH], et al) [X] 2,4-13,15,17-25,29-32 * claims, examples *[Y] 1-13,15-32 | Cited in | by applicant | Type: | Patent literature | Publication No.: | WO02059116
| Type: | Patent literature | Publication No.: | WO03002560
| Type: | Patent literature | Publication No.: | WO03031443
| Type: | Patent literature | Publication No.: | WO03032962
| Type: | Patent literature | Publication No.: | WO2004096221
| Type: | Patent literature | Publication No.: | WO2005023801
| Type: | Patent literature | Publication No.: | WO2005058888
| Type: | Patent literature | Publication No.: | WO2007017828
| Type: | Patent literature | Publication No.: | WO2008056335
| Type: | Patent literature | Publication No.: | WO2008062379
| Type: | Patent literature | Publication No.: | WO2009136379
| Type: | Patent literature | Publication No.: | US8329908
| Type: | Patent literature | Publication No.: | US8513231
| Type: | Non-patent literature | Publication information: | - NATIONAL HOSPITAL DISCHARGE SURVEY ANNUAL FILES 1996-2009, (20130522), URL: http://www.cdc/nchs/nhds.htm | Type: | Non-patent literature | Publication information: | - TILLOTSON GS; TILLOTSON J, "Clostridium difficile - a moving target", F1000 MEDICINE REPORTS, (2011), vol. 3, page 6 | Type: | Non-patent literature | Publication information: | - PEPIN J; ALARY ME; VALIQUETTE L; RAICHE E; RUEL J; FULOP K; GODIN D; BOURASSA C, "Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada", CLIN INFECT DIS, (2005), vol. 40, pages 1591 - 1597 | Type: | Non-patent literature | Publication information: | - MILLER M; GRAVEL D; MULVEY M; TAYLOR G; BOYD D; SIMOR A; GARDAM M; MCGEER A; HUTCHINSON J; MOORE D, "Health care-associated Clostridium difficile infection in Canada: Patient age and infecting strain type are highly predictive of severe outcome and mortality", CLIN INFECT DIS, (2010), vol. 50, pages 194 - 201 | Type: | Non-patent literature | Publication information: | - YOO J; LIGHTNER AL, "Clostridium difficile infections: what every clinician should know", THE PERMANENTE JOURNAL, (2010), vol. 14, pages 35 - 40 | Type: | Non-patent literature | Publication information: | - WENISCH JM; SCHMID D; TUCEK G; KUO HW; ALLERBERGER F; MICHL V; TESIK P; LAFERL H; WENISCH C., "A prospective cohort study on hospital mortality due to Clostridium difficile infection.", INFECTION, (2012), vol. 40, no. 5, pages 479 - 484 | Type: | Non-patent literature | Publication information: | - DENÈVE C; JANOIR C; POILANE I; FANTINATO C; COLLIGNON A, "New trends in Clostridium difficile virulence and pathogenesis", INT J ANTIMICROB AGENTS, (2009), vol. 33, doi:doi:10.1016/S0924-8579(09)70012-3, pages S24 - S28, XP026010678 | DOI: | http://dx.doi.org/10.1016/S0924-8579(09)70012-3 | Type: | Non-patent literature | Publication information: | - STUART H. COHEN, MD; DALE N. GERDING, MD; STUART JOHNSON, MD; CIARAN P. KELLY, MD; VIVIAN G. LOO, MD; L. CLIFFORD MCDONALD, MD; JA, "Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA", INFECT CONTROL HOSP EPIDEMIOL, (2010), vol. 31, no. 5, doi:doi:10.1086/651706, pages 431 - 455, XP055144254 | DOI: | http://dx.doi.org/10.1086/651706 | Type: | Non-patent literature | Publication information: | - PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING 11TH INFORMATIONAL SUPPLEMENT, (200101), vol. 21, no. 1, pages M100 - 511 | Type: | Non-patent literature | Publication information: | - NCCLS, (200701), vol. 27, no. 1, pages M100 - S16 | Type: | Non-patent literature | Publication information: | - KATO H; KATO N; WATANABE K; IWAI N; NAKAMURA H; YAMAMOTO T ET AL., "Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR", J CLIN MICROBIOL, (1998), vol. ;36, pages 2178 - 82, XP002629607 | Type: | Non-patent literature | Publication information: | - HUANG H; WEINTRAUB A; FANG H; NORD CE., "Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of Clostridium difficile infections.", J CLIN MICROBIOL, (2009), vol. 47, pages 3729 - 31 | Type: | Non-patent literature | Publication information: | - STUBBS SL; BRAZIER JS; O'NEILL GL; DUERDEN BI, "PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes", J CLIN MICROBIOL, (1999), vol. 37, pages 461 - 3, XP007906905 | Type: | Non-patent literature | Publication information: | - RASHID MU; LOZANO HM; WEINTRAUB A; NORD CE, "In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden", ANAEROBE, (2013), vol. 20, pages 32 - 5 |